Sharp Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$441K Buy
479
+28
+6% +$28.4K 0.22% 62
2025
Q4
$485K Hold
451
0.24% 59
2025
Q3
$344K Buy
451
+20
+5% +$14.9K 0.19% 73
2025
Q2
$336K Buy
431
+50
+13% +$38.9K 0.22% 55
2025
Q1
$315K Buy
381
+55
+17% +$45.8K 0.24% 58
2024
Q4
$252K Hold
326
0.19% 81
2024
Q3
$289K Buy
326
+16
+5% +$14.4K 0.22% 72
2024
Q2
$281K Hold
310
0.24% 78
2024
Q1
$241K Sell
310
-120
-28% -$85.4K 0.22% 80
2023
Q4
$251K Buy
+430
New +$251K 0.27% 68

Other funds holding LLY

Sharp Financial Services's LLY Position: Q1 2026 in Review

Sharp Financial Services increased its Eli Lilly (LLY) stake by 6.2% in Q1 2026, buying an estimated $28.4K and bringing the position to 479 shares worth $441K. The position accounts for 0.22% of the portfolio, ranked #62.

Sharp Financial Services first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $485K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sharp Financial Services held 479 shares of Eli Lilly worth $441K as of Q1 2026.
  • Sharp Financial Services bought 28 Eli Lilly shares in Q1 2026, an estimated $28.4K.
  • Eli Lilly made up 0.22% of Sharp Financial Services's portfolio in Q1 2026, its #62 holding.
  • Sharp Financial Services first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Sharp Financial Services's Eli Lilly position peaked at $485K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sharp Financial Services's 13F filing for Q1 2026, filed 27 Apr 2026.